Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Apr 16, 2009

Premium

Dionex announced this week that Frank Witney will become its president and CEO effective April 30, replacing Lukas Braunschweiler, who resigned late last year to become CEO of Ruag Holding.

Witney joins Dionex from Affymetrix where he was executive vice president and chief commercial officer. Prior to that he was president and CEO of Panomics from July 2002 until it was acquired by Affymetrix in December 2008.


Protein Forest said this week John Tonkinson was appointed to the newly created position of vice president of global sales and marketing. His appointment took effect March 16.

Tonkinson's responsibility is to grow sales by growing the current sales team and position Protein Forest in the marketplace "based on its development of products and services," the company said in a statement.

He was with HistoRx as vice president of business development before joining Protein Forest.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.